Nanaka, each study gives a unique result. There are variables between the study that showed the 54% reversal in age one of which is gender which had been flagged much earlier by us. We are looking at conducting a replication study with male rats but even that can have variance in clock results hopefully by not more than 10% to 20% on either side: meaning it can be lower or higher than last time. There is a big step of dose standardization as part of the development of E5. Only when this is complete will that variance go below 5%. I do believe that E5 platform has the potential to significantly reverse systemic biological age in all.

BOOOOM!!!